THSTI team participated in DST-CII India Netherlands Technology Summit, 15-16th October 2019, New Delhi
This year, India celebrated the 25th edition of Technology Summit, with the Kingdom of Netherlands being the partner country. DST-CII Technology Summit was inaugurated jointly by H.M. King Willem – Alexander, King of Netherlands and Dr. Harsh Vardhan, Minister of Science & Technology, Earth Sciences, and Health, Government of India on 15th October 2019 at Hotel J W Marriott, Aerocity, New Delhi.
The Summit had 1000+ delegates, 190+ delegates from the Netherlands, and over 200+ speakers from across the globe to deliberate on topics like Emerging Technologies for Agriculture, Water & Health, Design for Societal Challenges, Sustainable solutions for Waste Management and many more. This high-profile bilateral platform was formed to provide an opportunity to industry, institutes and government agencies from India and Netherlands to interact with each other. The forum was to forge partnerships, co-create joint ventures, and explore new avenues for collaborations. Prof. Gagandeep Kang was invited as speaker/panelist in the affordable health care session; 2a. Value track approach for affordable and innovative health care partnerships. In addition, she co-moderated the session Roundtable on Vaccines and Therapeutics along with Mr. Thijs Veerman (CEO, Operational Director, Progress-executive services (EXS). The leaders from different sectors (science, government, NGOs, industry, policymakers, regulators) joined in 3600 roundtable discussion to define opportunities in the healthcare and life science sector to broaden strategic collaborations between Dutch and India ecosystems, clusters and campuses. The participation of THSTI in this tech summit is an important starting point for possible collaboration and cooperation with Netherlands major key players in R&D. Drs. Dinesh Mahajan, Niraj Kumar, Sanjay Banerjee and Sweety Samal participated in B2B discussions in the area of vaccines, AMR, biotherapeutics to explore opportunities for existing and new strategic partnerships with Dutch R&D stakeholders.